7 new domestically produced Class 1 anti-ED drugs are coming, and Yangtze River sprints for the first time!
"K drug" hit the first shot, bringing new changes to the treatment pattern of esophageal cancer
FDA Approves Pembrolizumab for First-line Indications for Esophageal Cancer; China's First RET Inhibitor Pratinib Approved|Tumor News
"Ketoconazole + Octreotide", "Osilodrostat"... Will these become new methods of Cushing's treatment?
"Li" creates extraordinary, "Da" has a promising future│Taboshu® is launched in the new indication
Most people infected with the new coronavirus in Wuhan are asymptomatic. Can antibody levels prevent secondary infections?
[Science Sub-Journal] New breakthroughs in cell recombination programming | Cell therapy can help
Questioned that the data is out of date, AstraZeneca announces the clinical data of the new crown vaccine
Daily review of epichlorohydrin: a new low
Daily review of BPA: external bad news
PAWNN score predicts hospital death risk of new crown patients
Comparison of breeding stocks of sows: New Hope has the largest increase, Muyuan shares
Sub-Journal of "Cell": The new coronavirus can evade antibodies in the nose!
AstraZeneca announces Phase 3 data for new crown vaccine
The ideal disease-modifying drug for multiple sclerosis under the new crown epidemic, have you chosen the right one?
BPA daily review: bad news is still there
Treat To Target, a picture to understand the "new" concept of the treatment of reflux esophagitis!
Nat Hum Behav: New research links genes to the function of the human brain
Nat Comm | Huang Haojie's team reveals a new mechanism of resistance in prostate cancer
New natural enemy of tumor?